Clinical Trial

Study of CD38 and CD56 in Chronic Myeloid Leukemia

Name: Study of CD38 and CD56 in Chronic Myeloid Leukemia — clinical trial record (NCT07740603)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting

View on ClinicalTrials.gov →

Summary

Chronic myeloid leukemia is a myelo-proliferative neoplasm characterized by abnormal proliferation of myeloid cells. There is an accumulation of mature granulocytes in the blood and bone marrow. The aim of the study is to study expression of CD38 and CD56 in patients with Chronic myeloid leukemia.

Trial Details

NCT Number	NCT07740603
Lead Sponsor	Sohag University
Conditions	Chronic Myeloid Leukemia (CML)
Enrollment	200 participants
Start Date	2026-09-01
Primary Completion	2027-06-01 (estimated)
Study Completion	2027-07-01 (estimated)
Updated on ClinicalTrials.gov	2026-08-05